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Abstract
Antibiotic resistance is increasing worldwide and is considered a severe threat
to public health. Often, antibiotic resistance is caused by antibiotic resistance
genes, of which many are hypothesized to have been transferred into human
pathogens from environmental bacteria. It is, therefore, of great importance
to explore bacterial communities to identify new antibiotic resistance genes
before they reach clinical settings. The six papers presented in this thesis aim
to identify new antibiotic resistance genes in large genomic and metagenomic
datasets and to place them in an evolutionary context. In Paper I, a new
method for the identification and reconstruction of new antibiotic resistance
genes directly from fragmented metagenomic data was developed and was shown
to outperform other methods significantly. In Papers II and III, novel genes of
the clinically important class metallo-β-lactamases were identified. By analyzing
metagenomes and bacterial genomes, 96 novel putative metallo-β-lactamase
genes were predicted. In Paper IV, the diversity and phylogeny of the metallo-
β-lactamases were further investigated. The results showed that the genes
mainly clustered based on the taxonomy of the host species and that many of
the mobile metallo-β-lactamases potentially were mobilized from species of the
phylum Proteobacteria. In Paper V, the aim was to identify new genes providing
resistance to the antibiotic class tetracyclines. A total of 195 gene families
were predicted, of which 164 were new putative tetracycline resistance genes.
Finally, in Paper VI, we searched for and predicted 20 novel putative quinolone
resistance (qnr) genes from a large amount of metagenomic data. Throughout
the thesis, a total of 54 novel genes have been functionally verified in Escherichia
coli, of which 37 expressed the predicted phenotype. The results of this thesis
provide deeper insights into the diversity and evolutionary history of three
major classes of antibiotic resistance genes. It also provides new methodologies
for efficient and reliable identification of new resistance genes in genomic and
metagenomic data.
Keywords: antibiotic resistance, metagenomics, big data, β-lactamases, car-
bapenemases, tetracycline resistance, hidden Markov model.
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1 Background
Antibiotics are substances that can kill or inhibit the growth of bacteria. Since
their discovery in the early 20th century, they have saved millions of people from
life-threatening bacterial infections and have facilitated major improvements in
medicine and surgery. An antibiotic can either be a natural product produced
by specific microorganisms, synthetically constructed, or a combination thereof.
Over the past 60 years, most antibiotics have resulted from natural produc-
tion by bacteria or fungi, with a few exceptions of synthetically constructed
antibiotics (Walsh, 2003). There are several classes of antibiotics, but the
majority of them were discovered between 1940 and 1962, and since then, only
two new classes have been introduced (Coates et al., 2011; Tacconelli et al., 2018).
Antibiotic resistance is the ability of bacteria to withstand the effects of antibi-
otics, and consequently, medicines previously used to treat infections become
ineffective. Bacteria can withstand antibiotics through different resistance
mechanisms, which can be classified as intrinsic, adaptive or acquired. Bacteria
with intrinsic resistance have some inherited characteristics that cause them
to be unaffected by antibiotics, and this is a feature of all members of the
species. This characteristic does not change over time; an example is the outer
membrane of many Gram-negative bacteria, which is impermeable to certain
types of antibiotics (Carlos, 2015). The second variant of resistance is adaptive
resistance or stress response, where sudden changes in the environment of a
bacterial community trigger defense systems that can limit the permeability of
the outer membrane or overexpress eﬄux pumps, which leads to a decreased
accumulation of antibiotics and thus a decreased susceptibility (Carlos, 2015).
Finally, bacteria can also acquire resistance via mutations and horizontal gene
transfer of resistance genes. Through mobile genetic elements such as plasmids
and transposons, these resistance genes can move between bacterial cells and
species (Stokes and Gillings, 2011), and once obtained, the acquired resistance
can be inherited by daughter cells of the bacteria. Horizontal gene transfer has
played a vital role in the evolution of prokaryotes and can lead to fast changes in
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the genetic compositions of these organisms. Furthermore, if there is a positive
selection for the acquired resistance genes then the probability for the bacteria
to keep the new genetic elements will increase, as will the probability for the
spread to a larger community (Thomas and Nielsen, 2005).
Among the first antibiotics used commercially was penicillin in the 1940s,
but almost immediately after its release, a bacteria-produced enzyme with the
ability to hydrolyze penicillin was discovered. (Abraham and Chain, 1940).
New types of antibiotics were developed in response to increasing resistance,
but soon after a new drug was on the market, a new type of resistance was
discovered. Today, resistance to almost every developed antibiotic has been
recognized (Ventola, 2015), estimated to result in 700 000 deaths every year
and threatening our ability to perform key medical procedures (O’Neill et al.,
2016). Over time, antibiotic-resistant bacteria have undergone development
from resistance to single classes of antibiotics to being multi-drug resistant, often
through horizontal gene transfer. In clinical settings, some of the most problem-
atic resistant bacteria are the extended-spectrum β-lactamase (ESBL)-positive
Enterobacteriaceae, while other common types are the Methicillin-resistant
Staphylococcus aureus (MRSA) and the vancomycin-resistant enterococci (VRE)
(Cantas et al., 2013).
As a last-resort treatment for a patient infected with a multiresistant bac-
teria, the β-lactam antibiotics carbapenems are often used. However, recent
studies have shown that resistance to this antibiotic is emerging worldwide. The
resistance to carbapenems is to a large extent due to the expression of carbapen-
emases, a class of enzymes where the majority have broad-spectrum substrate
profiles (Papp-Wallace et al., 2011). An especially worrisome carbapenemase is
the acquired NDM-1, which was first discovered in 2009 (Yong et al., 2009). In
only a few years, the encoding gene had rapidly spread through pathogens and
has now been found in several geographical locations and isolated in numerous
bacterial species (Walsh et al., 2011), showing how fast new forms of resistance
genes can become a serious problem.
1.1 Antibiotic resistance and the environment
Antibiotics have been naturally produced by environmental microbial communi-
ties since ancient times, with some estimates pointing back to two billion years
ago (Hall and Barlow, 2004). As a result of evolution, antibiotic resistance has
likely been around for a similarly long time (D’Costa et al., 2011). This has
given the microbes ample time to develop a large and diverse set of resistance
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genes, a resistome, with most of them still undiscovered.
It is clear that the increase in antibiotic usage in human and veterinary set-
tings, together with the greater movement of people and animals, has led to
the increased prevalence and spread of antibiotic-resistant bacteria (Martínez,
2008; Cantas et al., 2013). Although some human pathogens are intrinsically
resistant to certain antibiotics, many of the pathogens are not originally carriers
of antibiotic resistance genes (ARGs). Instead, many of the ARGs encountered
in clinical settings are hypothesized to have originated from the environment
(Walsh, 2013). Resistance genes similar and identical to those in pathogenic
bacteria have been discovered in various environmental communities (Riesenfeld
et al., 2004a; Canton, 2009; Boulund et al., 2012), including pristine environ-
ments such as glaciers (Segawa et al., 2013) and 30 000-year-old permafrost
samples (D’Costa et al., 2011). However, the exact origin of most of these genes
is unknown. Furthermore, environmental and commensal bacterial communities
have been shown to harbor a vast diversity of ARGs, among which many have
not been identified in clinical settings (Sommer et al., 2009; Forsberg et al., 2012;
Wichmann et al., 2014). It has further been shown that selection pressures, such
as antibiotic exposure, may enrich the abundance and diversity of resistance
genetic elements in these communities (Gillings and Stokes, 2012). It is therefore
likely that the environment has and will continue to act as a reservoir for ARGs
that can be spread to pathogenic bacteria (Allen et al., 2010).
1.2 DNA sequencing
All known living organisms depend on their genetic material to function and
grow. Genetic information is encoded in two forms of nucleic acids, where
deoxyribonucleic acid (DNA) acts as repositories and ribonucleic acid (RNA)
acts as transmitters. DNA molecules generally contain four types of nucleotides,
namely, adenine (A), thymine (T), guanine (G) and cytosine (C), and RNA has
the same nucleotides except that T is replaced with uracil (U). Depending on
how these nucleotides are organized, they determine an organism’s functions
and traits. In each cell in every organism, a copy of the complete set of genetic
information is stored, which is called the genome. The size of genomes is highly
variable, with the genomes of the smallest viruses having a few thousand bases
compared to the more than three billion bases of the human genome and even
more in some species. Most genomes consist of a large number of genes, which
are parts of the genome that contain information about the synthesis of RNA
and proteins (Mathews et al., 2000).
4 1. Background
In the early 1950s, when it was discovered that proteins are constructed by
amino acids in what appeared to be defined orders (Sanger, 1960), the search
for the blueprint for protein creation began. Although the existence of DNA
was proposed shortly thereafter (Watson et al., 1953), it was not until 1965
that the first nucleic acid molecule in the form of tRNA was sequenced (Holley
et al., 1965). The first DNA sequenced was from the bacteriophage λ, which
was completed in 1971 and consisted of 12 bases (Wu and Taylor, 1971), and
the first whole genome sequenced was that of another bacteriophage, φX with
5375 bases, in 1978. The length of the sequences continued to increase with the
first human chromosome sequenced in 1999 (Dunham et al., 1999), and in 2001,
the first draft versions of the human genome’s 3.2 billion bases were published
(Venter et al., 2001; Lander et al., 2001). The advancements in the sequencing
techniques had until then been achieved mainly with the Sanger method, also
referred to as "first-generation" sequencing, but over the past decade, several
new sequencing techniques have emerged. A large breakthrough was the develop-
ment of the high-throughput second-generation or "next-generation" sequencing
(NGS) techniques. The second-generation sequencing provided the ability to
produce millions of sequence reads in parallel, speeding up the process and sub-
stantially reducing the cost of each read. Although the sequence reads produced
with second-generation techniques are typically not as long and not as accurate
as those produced with Sanger technology, the great throughput of reads makes
the coverage of each DNA fragment high and, therefore, the final sequences
more accurate. Recently, next-generation sequencing technologies have been
further developed with the aim of producing even longer reads while maintaining
the low price per read achieved with the second-generation techniques (van
Dijk et al., 2014). The rapid development of sequencing techniques has created
an enormous amount of sequence data, and today, there are approximately
200 000 sequenced bacterial genomes that are publicly available (NCBI, 2019),
compared to only 300 sequenced bacterial genomes a little more than a decade
ago (Land et al., 2015).
The massive amount of genomic data has provided us with unprecedented
opportunities to study all life forms on earth. The applications are numerous,
ranging from evolutionary studies to disease prevention. With even better and
faster sequencing techniques, together with new algorithms to process the data,
the number of applications will most likely be endless.
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1.3 Metagenomics
It is estimated that there are over 1030 individual bacterial cells (Whitman et al.,
1998) and between 107 and 109 bacterial species on earth (Curtis et al., 2002;
Dykhuizen, 1998). Historically, the study of microorganisms has been focused on
culturing of single species, but the vast majority of all microorganisms cannot be
cultured with standard techniques (Hugenholtz et al., 1998). The uncultivable
microorganisms represent many diverse organisms living in several unique com-
munities, and they are often distantly related to the cultivable ones (Riesenfeld
et al., 2004b). It is therefore important to develop culture-independent methods
to understand the ecological role of these communities, their genetic diversity
and population structure. To address this challenge, a technique that is now
called functional metagenomics was developed (Handelsman et al., 1998). In this
technique, DNA is taken directly from environmental communities rather than
from a single organism and fragmented into pieces. The DNA fragments are
then inserted into cultivable bacteria that are grown under certain conditions,
such as under antibiotic exposure, to assess the community for specific genes.
The collective genome of all organisms present in a community is named the
metagenome.
However, functional metagenomics has some drawbacks; the procedure is
time-consuming, and not every gene can be expressed in a cultivable host.
Furthermore, when searching for a specific type of gene, many fragments must
be created to ensure that the complete gene is captured by the inserted frag-
ments. However, with cheaper and faster sequencing techniques, the sequencing
of uncultured microorganisms directly from their community became possible
(Heather and Chain, 2016). The technique, often called shotgun metagenomics,
is the direct isolation and sequencing of genomic DNA from a bacterial commu-
nity through high-throughput DNA sequencing (Wooley et al., 2010). However,
the many benefits of metagenomics are accompanied by some complications.
Compared to single-organism sequencing where the whole genome of a specific
species is sequenced, metagenomic data often contain DNA from a large number
of species, and due to the high diversity generally present in and in-between
microbial communities, metagenomes are often undersampled. Furthermore, the
data are usually highly fragmented, with fragments occasionally as short as 75
bases, depending on which sequencing technique is used. The result is a dataset
that is difficult to reconstruct through sequence assembly, and it is often not
possible to reconstruct the complete genomes of the organisms present in the
sampled community. The analysis of metagenomic data is therefore challenging
and requires specifically designed methods and algorithms (Quince et al., 2017).
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Over the past years, several large projects have been conducted within the
metagenomic area, including the study of the gut microbiomes of 124 European
individuals, which resulted in the first human gut gene catalog (Qin et al., 2010).
Then, the Human Microbiome Project was presented (Consortium et al., 2012),
where scientists discovered, among others, that the microbial communities be-
tween body sites of healthy individuals remarkably differed. In the Tara Ocean
project, 7.2 trillion bases of metagenomic data have been sequenced, leading
to a new picture of the diversity within the ocean with more than 40 million
nonredundant genes discovered (Armbrust and Palumbi, 2015).
Historically, studies of antibiotic resistance have been conducted in clinical
settings with pathogenic bacteria. However, to elucidate the actual diversity
and abundance of resistance genes, it is necessary to focus investigations on the
environmental and commensal bacterial communities (Bengtsson-Palme and
Larsson, 2015; Berendonk et al., 2015). Because the majority of bacteria inhab-
iting these communities are uncultivable under standard laboratory conditions,
the development of metagenomics has provided an unprecedented opportunity
to explore these environments under unbiased conditions. Metagenomics offers
the means to investigate whole bacterial communities for many resistance genes
in parallel, leading to estimates of the present resistome and the possibility to
compare the resistomes between different environments (Bengtsson-Palme et al.,
2017b). Indeed, in recent years, several studies have focused on quantifying
resistance genes in environments such as sewage treatment plants (Yang et al.,
2013, 2014), pharmaceutical-polluted environments (Kristiansson et al., 2011;
Bengtsson-Palme et al., 2014) and the human gut (Forslund et al., 2013). Re-
cently, this approach has also been used as a way to monitor and compare the
trends of antibiotic resistance at both local and global scales (Hendriksen et al.,
2019; Huijbers et al., 2019). Furthermore, metagenomics makes it possible to
screen large amounts of data for new ARGs. The identification of previously
uncharacterized genes can help elucidate the evolutionary origin and history
of the ARGs that are presently encountered in clinical settings. Therefore,
analyzing and investigating the environmental resistomes, where in some cases
the majority of the ARGs are expected to be new, is crucial for better under-
standing the selection pressures and dissemination routes that facilitate the
mobilization and spread of ARGs (Larsson et al., 2018).
2 Aims
All papers included in this thesis are motivated by the overall aim to extend
the knowledge of the unknown resistome through identifying novel antibiotic
resistance genes in DNA sequence data. Paper I is dedicated to the development
and assessment of a method with the ability to identify previously unknown
antibiotic resistance genes from fragmented metagenomic data. In Papers I-VI,
the method is applied to identify antibiotic resistance genes of different classes
to further elucidate their diversity and abundance. To trace events of horizontal
gene transfer and evolutionary origin, the identified genes are placed into an
evolutionary context by comparing them to previously known genes (Papers II,
IV and V). More specifically, the aims of this thesis are to
1. develop and evaluate methods for the identification of novel antibiotic
resistance genes in genomes and metagenomes (Papers I-II).
2. predict novel β-lactamases, with a particular focus on carbapenemases, in-
vestigate their diversity and experimentally validate their function (Papers
I-IV).
3. predict novel tetracycline resistance genes; investigate their diversity; and
experimentally validate their function (Paper V).
4. predict novel quinolone resistance (qnr) genes, investigate their diversity
and validate their function (Paper VI).
5. investigate the evolutionary aspects of antibiotic resistance genes using
phylogenies inferred from both new and previously known genes (Papers
II, IV-V).
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3 Identification and analysis
of antibiotic resistance genes
Most of the work in this thesis is related to the identification and analysis
of antibiotic resistance genes (ARGs) from sequencing data. A wide range of
approaches has been developed for this purpose, and the choice depends on
several factors, such as the objectives of the study, type of data and available
computational power. This chapter provides a methodogical background to the
area of identifying known and novel ARGs, from the DNA sequencing to the
final analysis of the predicted genes. Figure 3.1 presents an overview of some of
the major steps in the workflow when searching for ARGs.
3.1 Generating and assembling sequence data
The emergence of cost-effective, high-throughput next-generation sequencing
(NGS) technologies in the mid-2000s drastically changed the bioinformatical
landscape, with an explosion of large datasets as a result. Today, several com-
mercially available DNA sequencing platforms are available, such as Illumina
(Solexa), 454, Ion Torrent and SOLiD sequencing (Liu et al., 2012), and depend-
ing on the technique used, the properties of the generated sequence reads will
vary. In addition to these methods, new techniques such as SMRT (PacBio)
(Rhoads and Au, 2015) and Oxford Nanopore (Clarke et al., 2009) have emerged
and are occasionally referred to as third-generation sequencing. What all these
techniques have in common is that they do not require DNA amplification
and are capable of sequencing single molecules, which is in contrast to most
of the early NGS techniques. These new techniques are capable of producing
significantly longer reads, up to and beyond hundreds of kilobases (Goodwin
et al., 2016). Although the sequencing platforms that produce long sequence
reads are continuously improving, the higher cost and error rate makes them
9
10 3. Identification and analysis of antibiotic resistance genes
Metagenomic sample Isolate
Assembly
Sequencing
Alignment of reads
to reference database
Sequence alignment to 
reference database
Phenotypical screening on
antibiotic-containing media
Inserts in cloned vectors
Abundance profile Identified ARGs
Figure 3.1: This flowchart shows possible workflows for the identification of ARGs.
Isolate samples can be sequences straight away whereas metagenomic samples can
be either sequenced directly or have the DNA inserted into cloned vectors that are
incorporated into host bacteria which are grown on antibiotic-containing media, as a
way to isolate the resistance genes. Once sequenced, the generated reads can either
be subjected to a de novo assembly or aligned to a reference database. The aligned
reads can be used to estimate the abundance of ARGs in the sample, and they can
also proceed to an assembly. Assembled contigs can be aligned to reference databases
to identify full-length ARGs.
inapplicable for some studies.
As a result of the short read lengths produced by many of the NGS techniques,
there is often a need to assemble the short reads into longer sequences, i.e.,
reconstructing the, or parts of, sequenced genome. This process is called an
assembly. The vast increase in short-read datasets has led to a high demand
for efficient and accurate assembly algorithms. For whole-genome shotgun
sequencing data, where a single organism is sequenced, the assembly algorithms
have been continuously improved, and today, the main challenge with whole-
genome assembly is accurate reconstruction in regions with repetitive DNA
segments. Some of these issues have, however, been resolved using the new
sequencing techniques with longer reads to gap the missing regions (Goodwin
et al., 2016). Metagenomic data, however, consist of several different organisms,
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and to obtain an accurate overview of the microbiome, there is a need to have
a high sequencing depth, which leads to large datasets, often on the order of a
billion reads. Here, the assembly is a highly intricate task, where, disregarding
the sheer number of reads, the objective is to piece together the shuﬄed reads
from several unknown organisms rather than assemble the genome of a single
organism (Quince et al., 2017). Therefore, there are complications related to
metagenomic assemblies that are not present for whole-genome assembly. For
instance, several individuals from the same species could have small genetic
variants, and entirely unrelated genomes may contain almost identical DNA
segments, as is the case if they carry mobile genetic elements (Ayling et al.,
2019).
Today, there are algorithms and software packages specifically developed to
handle the complex metagenomic data and to achieve de novo assemblies (Wang
et al., 2019), such as MetaVelvet (Namiki et al., 2012), Meta-IDBA (Peng et al.,
2011), MEGAHIT (Li et al., 2015), Ray (Boisvert et al., 2010), IDBA-UD (Peng
et al., 2012) and metaSPAdes (Nurk et al., 2017). However, these algorithms
are computationally demanding and memory intensive, and for large datasets,
these algorithms must be performed on computer clusters. Although it is
possible to assemble smaller datasets on a reasonably large server, some datasets
are not feasible to assemble locally due to memory, computational, and time
requirements. There are different tactics to overcome this problem. One is
to skip the de novo assembly and instead perform guided targeted assembly,
where reads are mapped to available genes and then assembled gene-wise using
tools such as MegaGTA (Li et al., 2017) and Xander (Wang et al., 2015).
Many approaches for studying metagenomic data often circumvent the assembly
altogether and perform the analysis, such as binning, mapping, or short read
alignment, directly on the sequence reads. However, information such as in what
organism the gene is located and the genetic context surrounding the gene, such
as potential mobile elements, will then be missed. Therefore, the need for de
novo assemblies is significant. Today, there is no perfect solution, and there is
therefore no doubt that the demand for improved algorithms and software that
perform metagenomic de novo assemblies is high and will continue to increase.
3.2 Methods for identifying resistance genes
There are many approaches that can be used for identifying resistance genes
in sequence data, where the complexity ranges from an alignment of a protein
sequence against a reference database to methods consisting of multiple steps
and classification procedures. The most appropriate method will mainly depend
on the objective of the study but also by the nature of the sequence data and
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the available computer resources. However, all methods can be divided into
two main categories: alignment-based methods and functional metagenomics.
Alignment-based methods are, in contrast to functional metagenomics, based
on sequence homology to known genes. Thus, if the study aims to identify
genes that have no sequence homology to previously characterized genes, then
functional metagenomics is the only available approach (see section 3.2.4).
Most of the alignment-based methods rely on sequence similarity searches
against a reference database, producing scored sequence alignments. Several
bioinformatics tools can perform this task, such as BLAST (Camacho et al.,
2009), DIAMOND (Buchfink et al., 2015) and UBLAST (Edgar, 2010). Although
sequence similarity searches against reference databases are often very useful in
identifying previously known genes, these methods are less suitable for detecting
distant homologs to known genes. For this purpose, methods based on profile
hidden Markov models (HMMs) (Eddy, 2011), which describe the conserved
regions and the variation between the genes, are better suited.
3.2.1 Databases
The performance when identifying ARGs heavily depends on how well-curated
and comprehensive the database is. Today, there are several publicly available
databases to choose from, and many of the databases display some overlap
in content. The most extensively used databases that specialize in antibiotic
resistance are ResFinder (Zankari et al., 2012), the Comprehensive Antibiotic
Resistance Database (CARD, (Jia et al., 2016)), Antibiotic Resistance Gene-
ANNOTation (ARG-ANNOT, (Gupta et al., 2014)), Resfams (Gibson et al.,
2015), Antibiotic Resistance Genes Database (ARDB, (Liu and Pop, 2008)),
MEGARes (Lakin et al., 2016), and Structured Antibiotic Resistance Genes
(SARG, (Yin et al., 2018)). In addition, the NCBI nonredundant protein
database (NCBI nr) contains all nonredundant protein sequences submitted to
NCBI.
The ResFinder database has specialized in acquired antimicrobial resistance
genes, is manually curated and also contains phenotypic information. In contrast
to ResFinder, the CARD and ARG-ANNOT databases are not limited to
acquired antimicrobial resistance genes but contain manually curated reference
data on antimicrobial resistance, including both intrinsic and acquired genes and
mutations involved in resistance. The MEGARes database contains manually
curated sequences from ResFinder, ARG-ANNOT, CARD, and the Lahey clinic
β-lactamase archive (Bush and Jacoby, 2010). MEGARes is also designed to
handle large metagenomic datasets through automated searches by streamlining
the annotation and structure of the database. The ARDB, focusing on all ARGs,
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has not been updated since 2009 but is together with CARD included in the
SARG (v.2) database, which also contains selected and curated sequences from
NCBI nr. The Resfams database consists of sets of protein families confirmed
for antibiotic resistance and associated profile HMMs.
3.2.2 Methods for analysis of whole genomes
For longer sequences such as whole genomes, plasmids and assembled contigs,
there is generally no need to complicate the method for identifying resistance
genes because the data are often manageable in size, and each segment contains
much more information compared to a short sequence read. Instead, it is a
question of what database and classification threshold to use. ResFinder,
Resfams, RGI (The Resistance Gene Identifier) and ARG-ANNOT are four
methods that use straightforward approaches for identifying resistance genes in
genomes, plasmids and contigs, with the main difference being the databases
and sequence alignment methods used (Table 3.1).
ResFinder is both a web-based and standalone method that aligns the input
data using BLAST against the ResFinder database (Zankari et al., 2012). The
classification is based on sequence similarity, and the best hits to acquired
resistance genes are displayed together with the resistance phenotype. The
web tool can take both whole genomes/contigs and fragmented data; however,
the fragmented data are assembled prior to the analysis using a dedicated
server such that the analysis is performed on the resulting contigs. Similar
to ResFinder, ARG-ANNOT performs a similarity search using BLAST to
identify resistance genes. Here, the analysis is performed through the tool
BioEdit (Hall et al., 2011), which enables the user to create their own database
and perform the search locally on a Windows computer, although the database
ARG-ANNOT is provided (Gupta et al., 2014). Resfams is a set of curated
profile HMMs, where gathering thresholds have been added to each of the profile
HMMs (Gibson et al., 2015). The analysis is performed using the software
HMMER (Eddy, 2011), and the specificity of the annotation will depend on
how specific the HMMs used are. Although Resfams is based on HMMs, the
models are not optimized to identify fragmented data; hence, the performance
for short sequence reads as input is poor, as has been shown in Paper I. RGI
is slightly more complex than ResFinder and Resfams, where the input data
are first analyzed for open reading frames (ORFs), which are then used as the
query sequences for a sequence similarity search against the CARD database
using either BLAST or DIAMOND. Here, the user can choose from among
three criteria for gene identification: Perfect, Strict and Loose. The Perfect
option only searches for perfect matches to the database. The Strict option
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can detect variants of previously known genes using curated similarity cutoffs,
while the Loose option will display hits that are below the cutoffs to enable the
identification of more distant homologs of previously known resistance genes
(Jia et al., 2016).
Table 3.1: An overview of bioinformatic tools to identify resistance genes in sequence
data.
Query type Classification method
ResFinder Assembled Alignment to ref. DB
Resfams Assembled Alignment to profile HMM
RGI Assembled Alignment to ref. DB
ARG-ANNOT Assembled Alignment to ref. DB
AmrPlusPlus Reads Alignment to ref. DB.
GROOT Reads Hierarchical local align. to variation graph
MEGAN Reads Alignment to ref. DB
ARIBA Reads Alignment to ref. DB
ARGs-OAP Reads Alignment to ref. DB
ARGs-OAP SARGfam Open Reading Frames Alignment to profile HMM
deepARG Reads & Assembled Alignment to ref. DB + Neural networks
fARGene Reads & Assembled Alignment to profile HMM
3.2.3 Methods for analysis of metagenomic reads
When the data of interest are fragmented metagenomic data, the analysis
becomes more complicated, which can be addressed by several approaches.
Because metagenomic data consist of fragments from several different organisms
and suffer from a wide range of noise (Boulund et al., 2018), an assembly of
the data requires extensive computer resources and is occasionally not even
practically feasible. Furthermore, metagenomic data are often undersampled,
and genes that are present in low abundance might be missed in the assembly
due to low coverage, while regions containing mobile genetic elements, where
many ARGs are located, are notoriously hard to assemble (Bengtsson-Palme
et al., 2014; Wu et al., 2012; Ellington et al., 2017). Instead, there are several
bioinformatic approaches developed to perform the analysis directly on the
short reads (Table 3.1).
Among the tools that provide resistome profiles is AmrPlusPlus. This tool can
analyze large metagenomic datasets and provides count files for each sample that
contain information on what resistance genes are identified in the samples and
its corresponding abundance (Grüning, 2016). The method operates on short
sequence reads that are quality controlled and then aligned to the MEGARes
database using the short-read mapping tool BWA (Li and Durbin, 2009). A
3.2. Methods for identifying resistance genes 15
similar tool is ARGs-OAP, which takes fragmented metagenomic samples as
input and offers ARG profiles for the data, including taxonomic profiles and
abundance analysis. The method consists of a two-step analysis, wherein the
short sequence reads in the first step are screened for 16S rRNA for taxonomic
profiling and potential ARGs using UBLAST against the database SARG. The
second step is once again a similarity search against the SARG database but this
time using BLASTX. Here, the limiting factor for finding new ARGs is the first
stage of the pipeline, where many potential ARG reads are discarded, which we
also show in Paper I. The SARG database also includes sets of profile HMMs
(SARGfam) that were created after phylogenetic analysis of the sequences in the
database, and gathering thresholds were set using leave-one-out cross-validation.
However, the specificity for the SARGfam is estimated from the analysis of
randomly chosen sequences from other types of resistance genes, which do not
necessarily have to be the sequences most likely to be classified as false positives.
The SARGfam is furthermore only accessible online and requires predicted
ORFs as input.
MEGAN is another tool used for the analysis of both the taxonomic and
functional compositions of large microbial datasets (Huson et al., 2016). Al-
though not specialized in the identification of resistance genes, this tool, to some
extent, includes functionality to do so. In the approach, short sequence reads
are mapped to the reference database NCBI nr using the DIAMOND aligner
(Buchfink et al., 2015). Then, both taxonomic and functional profiling are
performed based on NCBI taxonomy, SEED (Overbeek et al., 2013), eggNOG
(Powell et al., 2011) and InterPro2GO mapping of reads (Hunter et al., 2013;
Mitchell et al., 2014). A gene-centric assembly can then be performed, where all
reads assigned to a given functional node can be assembled and given as output.
However, because MEGAN does not offer any resistance gene database for bin-
ning, the performance for the identification of resistance genes is poor, mainly
due to the lack of resolution of the resistance-related genes in the database.
The method ARIBA (Antimicrobial Resistance Identification By Assembly)
(Hunt et al., 2017), similarly to MEGAN, takes fragmented metagenomic data
as input and then uses a targeted local assembly approach to identify resistance
genes. However, ARIBA has a more sophisticated classification scheme in which
the short-read data are mapped to the reference sequences using minimap (Li,
2016). The reference sequences consist of any of the databases ARG-ANNOT,
CARD, MEGARes or ResFinder that have been clustered by similarity before
use. Then, the mapped reads are assembled separately for each cluster, and
for each contig, the closest reference sequence is identified using the MUMmer
sequence alignment package (Delcher et al., 2003). The reads for each cluster
are mapped to the assembly using the read aligner Bowtie2 (Langmead and
Salzberg, 2012), from which potential sequence variants are identified. Com-
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pared to AmrPlusPlus and ARGs-OAP, ARIBA predicts full-length ARGs from
fragmented metagenomic data and is therefore able to identify potential muta-
tions and small sequence variations. However, when testing ARIBA’s ability to
identify genes distantly related to previously known genes, the method was not
able to predict a single gene (Paper I).
GROOT (Graphing Resistance Out of meTagenomes) takes metagenomic
sequence reads as input and applies a custom hierarchical local alignment using
a hashing-based indexing scheme for classification (Rowe and Winn, 2018). The
alignment is performed against a resistance database of choice, although GROOT
provides a database that is a combination of ResFinder, ARG-ANNOT, and
CARD where duplicated sequences have been removed. The chosen database is
prepared by clustering the sequences based on a 90% sequence similarity to group
the sequences into sets of similar genes. Each resulting set can be considered a
multiple sequence alignment, which is converted into a variation graph that uses
the multiple sequence alignment as the foundation. The alignment of sequence
reads is then performed using an approximate nearest-neighbor search to identify
the correct region of a graph followed by a hierarchical local alignment to obtain
a fully aligned read. If a read has been successfully aligned to a variation
graph, it is classified as antibiotic resistance derived, and gene annotations are
performed based on the reference information of the graphs.
The method deepARG can handle both full-length and short-read sequences
(Arango-Argoty et al., 2018). The classification consists of two steps, where
the first step is a sequence alignment using DIAMOND against a custom-made
resistance database based on sequences in the CARD and ARDB databases
together with manually selected sequences from the UNIPROT database with
the keyword antibiotic resistance. The results from the alignment then proceed
to a custom-made deep learning model (DeepARG), which will annotate the
sequences to antibiotic resistance categories. Although the method generally
has a high precision and recall, it is not optimal for discovering resistance genes
distantly related to the previously known, especially for short sequence reads, as
shown in Paper I. This is mainly due to the first alignment step to the reference
database, where many of the potential resistance genes are being discarded
because of their low alignment coverage. However, note that among the methods
validated in Paper I, deepARG was the one, except for fARGene, that had the
highest sensitivity for identifying short reads from distantly related ARGs.
In Paper I, the method fARGene (fragmented Antibiotic Resistance Gene
Identifier) is described. Compared to the competing methods, fARGene was
specifically developed to identify new ARGs from fragmented metagenomic
data. The method operates directly on short sequence reads that are aligned
to profile HMMs that are optimized for the identification of short sequence
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reads of resistance genes. The reads that are classified as belonging to the
resistance gene class of interest are retrieved together with their read pair and
then assembled using SPAdes meta (Nurk et al., 2017). Another classification
is performed on the assembled contigs but this time using a threshold score
optimized for full-length genes. The final output is predicted full-length ARGs.
For full details, see Chapter 4 and Paper I.
3.2.4 Functional metagenomics
Shotgun metagenomics has allowed us to study the taxonomical and functional
composition, including the resistome, of large microbial communities, including
uncultivable bacteria. However, all methods described above rely on prior
knowledge of the genes coding for resistance phenotypes to find them and their
homologs. It is possible to successively expand the known gene catalog by
predicting homologs to already know ARGS and perform functional verification
of the identified candidates, but it is almost impossible to identify genes with
little to no sequence identity to previously known ARGs through shotgun
metagenomics. Functional metagenomics, however, is a technique that, instead
of focusing on the similarity to known genes, focuses on the function of segments
of DNA inserted in an external host, such as Escherichia coli, and by doing
so can identify completely new ARGs. In a typical project that aims to
identify ARGs by functional metagenomics, the method starts by extracting and
preparing DNA from the microbial community of interest. Gene libraries are
then constructed by allowing the DNA to be cloned into vectors (e.g. plasmids)
that are incorporated into a host bacterium. Then, the bacterial clones are
plated onto agar plates containing antibiotics. The antibiotic should be of a
concentration such that it would kill the host bacteria that has not acquired any
resistance gene. The DNA sequences of the inserts of the surviving bacteria are
then determined, and ORFs can be predicted. There are, however, drawbacks
to this approach. First, the amount of cloned DNA is limited. Therefore,
genes that are low in abundance will often be missed. Furthermore, genes
that are not being functional in the host bacterium will not be discovered, and
the opposite is true when a gene that does not confer resistance in its native
host is functional in the host bacterium. However, the latter will still provide
information about the gene being able to confer resistance if being transferred
to another species other than the native species. Another issue is whether
the host bacterium is intrinsically resistant to the antibiotic being screened
for. One approach to overcome this problem is to use another host. Despite
these potential obstacles, functional metagenomics is still the only metagenomic
approach that can identify completely new ARGs (Mullany, 2014; Riesenfeld
et al., 2004a; Marathe et al., 2018).
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3.3 Phylogenetic analysis
When new ARGs are identified, it is common to compare them to the previously
known resistome to see how they relate to each other and hopefully understand
their evolutionary origin. For this purpose, an inferred phylogeny is often used.
Phylogenetic analysis can be described as our attempt to reconstruct the evolu-
tionary history of organisms. Following the rapid increase in sequenced DNA
and better computers, the ability to infer phylogeny has increased substantially,
and today, phylogenies are used in almost every part of biology. The subject of
molecular phylogeny is vast, and this section will only cover the basics with a
short background to some of the approaches used to infer phylogeny.
Typically, phylogenetic relationships are visualized using a phylogenetic tree.
The tree can be described as a branching diagram that displays the evolutionary
relationships among the studied biological entities. The trees can be either
unrooted or rooted, and the branching diagram of the tree is called a topology
(Figure 3.2). The branches connect the nodes, which can be viewed as the
start of a new lineage, while the branches represent the consistency of a genetic
lineage over time. The number of possible topologies is a function of the number
of sequences included in the analysis, and it increases drastically with increasing
number of sequences. Because a phylogenetic tree is inferred from data, it is a
challenging task, often even impossible, to find the true topology for large trees.
The methods to reconstruct a phylogenetic tree can be either distance- or
character-based, where the distance-based methods utilize the calculated dis-
tances between every pair of sequences, summarized in a distance matrix, while
the character-based methods compare all sequences simultaneously character
by character in a multiple sequence alignment. There are many approaches
that can be used to reconstruct a phylogenetic tree using the aforementioned
methods. The distance matrix methods include, for example, neighbor-joining,
least squares and minimal evolution, and for the character-based methods, we
have maximum parsimony, maximum likelihood and Bayesian inference methods.
Here, the distance matrix methods, maximum likelihood and Bayesian inference
all assume an underlying evolutionary substitution model to describe the data
and can therefore be described as model-based methods, whereas maximum
parsimony does not (Nei and Kumar, 2000; Yang and Rannala, 2012).
Parsimony methods were one of the first methods to be used for inferring phy-
logenies and are based on the assumption that the reconstructed evolutionary
events that lead to our given data should contain as few events as possible
(Cavalli-Sforza and Edwards, 1967; Fitch, 1971). In the maximum parsimony
method, this is incorporated by minimizing the number of changes on a phy-
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Figure 3.2: Rooted phylogenetic tree (a) and unrooted phylogenetic tree (b).
logenetic tree. The minimum number of changes required for a site is called
the character length, and the tree score is the sum of all character lengths
over all sites. Then, the tree that minimizes the tree score is the maximum
parsimony tree. The simplicity of parsimony trees makes them easy to interpret
and enables efficient computer programs to generate trees. However, simplicity
is also a major drawback because parsimony does not incorporate any knowledge
of the process of sequence evolution in tree reconstruction.
In distance matrix methods, the pairwise sequence distances are calculated
assuming a nucleotide substitution model in the form of a Markov chain. The
substitution models can assume an equal rate of substitution between any
two nucleotides or different rates between the substitution of T ↔ C and
A↔ G. Furthermore, the models can assume equal or unequal frequencies of
the four nucleotides. To accommodate the variation in the local mutation rate,
the distribution of rates for sites are often assumed to be gamma distributed
(Yang and Rannala, 2012). When the distance matrix is calculated, there are
several ways to reconstruct the topology. The least squares method attempts
to minimize the calculated distances in the distance matrix (dij) to that of the
expected distances in the tree (dˆij), i.e., the branch lengths, leading to a score
Q (Equation 3.1). The tree that has the smallest score will then be the least
squares estimate of the true tree (Fitch and Margoliash, 1967).
Q =
s∑
i=1
s∑
j=1
(dˆij − dij)2 (3.1)
In the minimal evolution method, the sum (S) of all branch length estimates
is calculated for all possible topologies, and the topology that minimizes S is
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chosen (Rzhetsky and Nei, 1992). Conversely, neighbor-joining also uses the
minimal evolution principle, but instead of examining all possible topologies, it
successively chooses a pair of taxa to join together based on the distances. Then,
the distance matrix is updated with the joined taxon, replacing the two original
taxa (Saitou and Nei, 1987). Distance-based methods are often computationally
efficient, especially neighbor-joining, which could be desirable when analyzing
large datasets. However, it is often important to choose the correct substitution
model, and the distance calculation can be problematic when there are divergent
sequences and many alignment gaps.
In maximum likelihood (ML) methods, for a specific substitution model, the
likelihood of observing a given set of sequence data is maximized for each
topology. The topology that yields the highest maximum likelihood is chosen
as the final tree. It is important to note that the resulting likelihood of a tree is
not the probability of the tree being the correct one (Felsenstein, 1981; Nei and
Kumar, 2000). In ML tree estimation, there are two steps: first, optimization
of branch length for each candidate tree, and then a search in the tree space for
the maximum likelihood tree. Furthermore, for the likelihood to be computed,
two assumptions must be made:
• On the given tree, evolution in different sites is mutually independent.
• Evolution in different lineages is independent.
Therefore, the overall likelihood for the tree is a product of the probabilities for
each site, where the probabilities depend on the substitution model used. The
likelihood of any particular site is computed by an average over the unobserved
character states at the ancestral nodes (Felsenstein, 2004).
Bayesian inference is a general statistical inference methodology that is closely
related to likelihood methods. In maximum likelihood, the model parameters
are considered to be fixed constants, whereas in Bayesian inference, they are con-
sidered to be random variables with probability distributions. The parameters
are assigned prior distributions that, when combined with the observed data,
generate a posterior distribution from which the inference is based. Bayesian
inference is based on Bayes’s theorem, which states that given a hypothesis T,
which in this case is a possible tree, and some observed data D, the probability
of the hypothesis given the data is
P (T )|P (D|H)
P (D)
. (3.2)
Since the normalization constant P(D) generally involves high-dimensional
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integrals and summation over all possible trees, the posterior probabilities
of trees are often impossible to calculate exactly. However, the posterior
distribution can be numerically estimated using Markov chain Monte Carlo
methods, without the need for determining the denominator P(D) explicitly
(Larget and Simon, 1999).
Although the Bayesian and ML methods share many properties, there is an
ongoing controversy regarding which one to use when drawing inferences from
data. Both methods have strengths and weaknesses. First, both methods
utilize explicit models, which can be chosen to best suit the data, which is
a significant advantage compared to maximum parsimony. Moreover, both
methods require heavy computation, which requires fast computers and smart
algorithms. The main difference is that the Bayesian methods use of prior
distributions, which allows for the incorporation of prior knowledge about the
system. The complication with priors is that such information is rarely available;
generally, the prior is set by the software, and an incorrectly chosen prior can
have an unexpected effect on the posterior (Yang and Rannala, 2012; Felsenstein,
2004).
In the papers presented in this thesis, phylogenies have been used to place the
identified genes into an evolutionary context. In the majority of the papers, an
approximate ML approach has been used (Price et al., 2010) due to the large
number of sequences and the aforementioned computational requirements for ML
trees. In Paper IV, however, we selected a smaller subset of all predicted genes
to infer phylogenetic trees using analytical ML. The reason for choosing the
ML over the other approaches was mainly because it uses complex substitution
models to describe the biology of the data and that there are parallelized
software available to perform the analysis (Stamatakis, 2014).
3.4 Functional verification
When new ARGs are predicted, it is important to perform a functional ver-
ification to verify that the gene confers resistance. If the isolate in which
the gene was found is accessible, the bacterium of interest can be grown on
antibiotic-containing media, and from there, a minimum inhibitory concen-
tration (MIC) can be obtained. However, this will not provide information
about whether the resistance is caused by the predicted gene or by some other
acquired or pre-existing mechanism. One solution is to construct the predicted
gene synthetically and then insert a vector that contains the synthetic gene into
a host bacterium that is susceptible towards the antibiotic of interest. Then,
the MIC can be determined for the cloned bacterium. In this case, a positive
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result shows that the gene is functional in the tested host, although it might
not be expressed in its original host. Conversely, a negative result does not
necessarily mean that the predicted gene is not a resistance gene. Instead, the
lack of function could be due to host incompatibility such that the gene could
be functional in its original- and other potential hosts. Here, there are some
approaches, such as codon optimization, that could be incorporated, but then
it is not the predicted gene that is tested but a synthetic modification of it, and
one could argue that because it is not naturally present in the environment, such
verification is pointless. The second issue is to determine a reasonable threshold
MIC value for considering a tested gene an ARG (Martínez et al., 2015). Here,
the purpose of the study will affect what is to be considered a resistance gene. If
the sole purpose is to show that the gene is functional, then a higher MIC value
than the same strain without the gene would be considered sufficient. However,
when the gene is expected to be functional but expressed at a low level in the
host bacterium, an increased MIC value can be difficult to detect. Then, more
sensitive methods are required, and in Paper V, a method that investigates the
growth behavior in the presence of antibiotics was used. Although the MIC
results for two predicted ARGs were inconclusive, the test showed a significant
increase in the growth rate of the host carrying the predicted genes compared
to the control in the presence of low concentrations of antibiotics.
4 Summary of results
This chapter provides a background and the main results of the six papers
included in this thesis.
4.1 Paper I
Antibiotic resistance can be an intrinsic trait of bacteria but may also be
acquired via mutations in existing chromosomal DNA or through the horizontal
transfer of genes (Blair et al., 2015). Environmental bacterial communities
harbor a large diversity of antibiotic resistance genes (ARGs) that can be
mobilized and spread to pathogenic bacteria either directly or via human- and
animal-related bacteria. Indeed, many of the current clinically relevant ARGs
are believed to have an environmental origin (Forsberg et al., 2012; Bengtsson-
Palme et al., 2017a). Furthermore, it has been shown that areas subjected to
intense selection pressure, such as pollution from antibiotics, can further increase
the abundance of ARGs (Gillings and Stokes, 2012; Bengtsson-Palme et al.,
2014). It is therefore essential to investigate the environmental and commensal
resistomes, including the previously uncharacterized ARGs, to understand the
evolutionary process behind their evolution and mobilization. Furthermore,
increased knowledge of the available resistome will facilitate surveillance and
enable confinement actions before new ARGs reach clinical settings.
Shotgun metagenomics provides a holistic approach to study the environmental
resistome via the sequencing of random fragments from a whole microbial
community. However, the data are often highly fragmented and suffer from
a considerable amount of noise. Assembly of the data is therefore often a
challenging task that requires substantial computational resources. Furthermore,
metagenomic data are often undersampled, which makes genes that are low in
abundance hard to assemble, as are genes located on mobile genetic regions.
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Metagenomic Data ARG Model
1: Fragment Classification 2: Gene Assembly
3: Verification and Post-processing
ARG ModelFull-length Antibiotic Resistance Genes
Figure 4.1: fARGene takes metagenomic paired-end data as input and analyzes
the data with a probabilistic gene model that classifies the reads as coming from a
resistance gene or not (Panel 1). The paired-end sequences of the positively classified
reads are extracted, quality controlled and then assembled into full-length genes
(Panel 2). The reconstructed gene sequences are once again classified by the ARG
model (Panel 3). The output consists of nucleotide and amino acid sequences of the
reconstructed full-length ARGs. The method can also be directly applied to whole
genomes and metagenomic contigs, and then the classification, extraction and assembly
of reads are not performed.
In Paper I, Identification and reconstruction of novel antibiotic resistance genes
from metagenomes, we developed and implemented the fARGene method, which
is specifically designed to identify and reconstruct novel ARGs from fragmented
metagenomic data without the need for de novo assembly. This method consists
of three main steps, and a schematic overview is presented in Figure 4.1. The
method starts by analyzing short sequence reads using a probabilistic gene
model in the form of a profile hidden Markov model (HMM) that has been
optimized to identify short reads of the ARG class of interest (panel 1 in Figure
4.1). The reads classified as belonging to the modeled ARG class are then
retrieved, together with their read-pair, even if only one of the reads in the pair
was classified as an ARG. This first classification step significantly reduces the
amount of data and enables the method to be computationally efficient. The
retrieved reads are then assembled using a paired-end assembler, enabling less
conserved regions at the end of the ARGs to be included in the assembly (panel
2, Figure 4.1). Then, the assembled contigs are once again subjected to the
model, but this time, the threshold score used is optimized for full-length genes
(panel 3, Figure 4.1). The contigs that are classified as belonging to the ARG
class of interest are retrieved and scanned for open reading frames (ORFs). The
ORFs are once again subjected to the full-length model, where the ORFs that
passed this classification are retrieved if they are longer than a specific length
4.1. Paper I 25
Domain score
0 10 20 30 40 50
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
 
0
0.2
0.4
0.6
0.8
1
Class A(a)
Domain score
0 10 20 30 40 50 60
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
 
0
0.2
0.4
0.6
0.8
1
Class B1+B2
Sensitivity
1-Specificity
Domain score
0 10 20 30 40 50
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
0
0.2
0.4
0.6
0.8
1
Class B3
Domain score
0 10 20 30 40 50 60
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
0
0.2
0.4
0.6
0.8
1
Class C
0 10 20 30 40 50 60
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
0
0.2
0.4
0.6
0.8
1
Domain score
Class D1
Domain score
0 10 20 30 40 50
Id
e
n
ti
fi
e
d
 f
ra
g
m
e
n
ts
0
0.2
0.4
0.6
0.8
1
Class D2
(b)
(c) (d)
(e) (f)
Figure 4.2: Results from the estimation of sensitivity and false positive rate (1-
specificity) for the four β-lactamase classes. Each figure shows the performance of
correctly classifying short reads as ARGs. The green curve represents the sensitivity,
i.e., the fraction of correctly identified ARG reads, while the orange curve shows the
false positive rate, i.e., the fraction of reads from genes without resistance phenotype
incorrectly classified as an ARG. The dashed line corresponds to the set threshold
score for each model.
threshold.
The method depends on optimized profile HMMs, and fARGene includes func-
tionality to create and optimize customized models of the ARG class of interest.
The optimization is based on leave-one-out cross-validation and is aimed at
achieving sensitivity that is as high as possible while keeping the false positive
rate low. For short-read data, this is achieved by excluding one gene at a
time from the dataset of ARGs of interest. The excluded gene is randomly
fragmented into short reads that are analyzed by a model created from the
remaining ARGs in the dataset, and this process is then repeated for each gene.
When estimating the false positive rate, it is important to carefully choose a
negative dataset, preferably one with genes that have high sequence homology
to the ARG class of interest but lacks the studied phenotype. The genes in the
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chosen negative dataset are then fragmented into short reads and analyzed by
the model created from the ARG class of interest. The sensitivity and false
positive rate are then estimated based on the proportion of correctly classified
reads, from which an optimal threshold score can be decided. The sensitivity
and false positive rate for full-length genes are estimated similarly as for the
short reads but by allowing the models to analyze full-length genes instead of
short reads. Here, the threshold score should preferably be set such that there
is a complete separation between the ARGs and the false positives.
As a case study, models were created to represent all genes within the four
classes A, B, C and D of the clinically important β-lactamases. To capture the
large sequence diversity within each class correctly, class B and D β-lactamases
were separated into two models each. For full-length genes, the models were able
to completely separate the ARGs from the negative dataset, while the threshold
score for short-read data was set to keep the sensitivity as high as positive while
keeping the false positive rate below 10% (Figure 4.2). The models were then
used to analyze almost five billion reads from five metagenomic datasets, from
which 221 ARGs were reconstructed, of which 58 were previously unknown
(<70% sequence similarity to any reported gene in NCBI GenBank). The
most commonly found gene class among the five datasets was class A with 149
reconstructed genes, followed by class B with 46, class D with 18 and class C with
10
-5
10
-4
10
-3
10
-2
10
-1
H
M
P
H
um
an
 g
ut
O
il 
sp
ill
Po
llu
te
d 
la
ke
W
ad
en
 S
ea
R
e
c
o
n
s
tr
u
c
te
d
g
e
n
e
s
p
e
r
m
il
li
o
n
re
a
d
s
Class A
Class B
Class C
Class D
Figure 4.3: Number of reconstructed full-length genes per million reads (y-axis) for
the four β-lactamase classes A, B, C and D.
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Figure 4.4: The ability to correctly classify short sequence reads for fARGene and
five competing methods. The performance of fARGene was consistently higher than
all compared methods.
8 reconstructed genes. The metagenome from an antibiotic-polluted Indian lake
was the environment in which the highest relative abundance of reconstructed
full-length genes for classes A, C and D was found, while full-length genes from
class B had the highest relative abundance in an oil-contaminated deep-sea
metagenome (Figure 4.3).
fARGene’s ability to identify novel ARGs in fragmented metagenomic data was
compared against five competing methods: deepARG (Arango-Argoty et al.,
2018), Resfams (Gibson et al., 2015), ARGs-OAP (Yin et al., 2018), GROOT
(Rowe and Winn, 2018) and MEGAN (Huson et al., 2016). fARGene had a
consistently higher sensitivity than all compared methods, with an average
sensitivity of 0.87 compared to 0.55 for deepARG and 0.52 for MEGAN, which
were the second and third best, respectively (Figure 4.4). In addition, fARGene’s
ability to identify and reconstruct novel full-length ARGs was compared against
the method ARIBA (Hunt et al., 2017), where fARGene was able to correctly
reconstruct all 168 tested ARGs compared to none for ARIBA. Hence, fARGene
offers both superior performance and the ability to reconstruct novel ARGs
from fragmented metagenomic data and therefore provides the means to study
the ARG composition of bacterial communities holistically. We also conclude
that fARGene enables exploration of the resistome at an unprecedented scale.
4.2 Papers II and III
Carbapenems are important broad-spectrum antibiotics that are often used
as a last-resort treatment for patients infected with multiresistant bacteria.
Carbapenem resistance is often caused by carbapenemases, enzymes that can
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often hydrolyze almost all known β-lactams in addition to carbapenems. Over
the past few years, resistance towards carbapenems has rapidly increased in many
regions of the world (Papp-Wallace et al., 2011), and carbapenem resistance
genes, which up until some years ago had never been seen, are now detected
in pathogens worldwide. The majority of mobile carbapenem resistance genes
have been identified in clinical settings, but it is hypothesized that these genes
originated from environmental bacteria. Many acquired and clinically relevant
carbapenem resistance genes, such as VIM, IMP and NDM, belong to the class
metallo-β-lactamases. This class is further divided based on molecular structure
into the three subclasses B1, B2 and B3. In Papers II and III, the aim was
to identify previously uncharacterized metallo-β-lactamases to obtain a more
detailed picture of the origin and diversity of this important resistance gene
class.
In Paper II, Identification of 76 novel B1 metallo-β-lactamases through large-
scale screening of genomic and metagenomic data, an early version of the
method fARGene, described in Paper I, was used to analyze more than five
terabases of metagenomic data from both human and environmental bacterial
communities, as well as bacterial genomes and plasmids available in the NCBI
GenBank database. The probabilistic model used was optimized to find new
metallo-β-lactamases of subclass B1 and was constructed using the 20 subclass
B1 genes previously verified as of that date. In total, 76 novel subclass B1
genes were identified, and when clustered together with all previously reported
subclass B1 genes using an amino acid sequence similarity cutoff of 70%, they
formed 59 novel gene families. A phylogenetic tree was created based on
one representative sequence from each of the 59 novel gene families together
with the previously reported subclass B1 genes (Figure 4.5). Analysis of the
resulting tree indicated that the genes could be organized into five groups,
mainly defined by the taxonomy of the host species. We further noticed that
all except one previously identified mobile subclass B1 gene clustered together
with chromosomally encoded genes of the phylum Proteobacteria, indicating
that many of the acquired subclass B1 genes have mobilized from species within
this phylum.
Of the identified novel genes, 21 were selected for experimental verification,
in which the genes were synthesized and inserted into an Escherichia coli
host. A CarbaNP test (Nordmann et al., 2012) was conducted, and the results
of this test showed that 18 of the tested genes had carbapenemase activity
(Table 4.1). Among the verified genes, there was one, named SPS-1, that
had a previously unseen binding site atypical for subclass B1. The results
from this paper significantly extended the number of identified subclass B1
metallo-β-lactamases and provided a more detailed picture of their diversity
and evolutionary history.
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Figure 4.5: A phylogenetic tree describing the evolutionary relationship between
the B1 metallo-β-lactamases predicted in this paper. The tree was created from
representative sequences for the gene families generated through clustering predicted
and previously characterized subclass B1 genes at a 70% amino acid sequence identity
cutoff. Previously characterized subclass B1 genes are annotated with the protein
name. Novel gene families predicted in this paper are annotated with the corresponding
family number and the source (metagenome or species name of the host). The numbers
in parentheses show how many unique genes there are in each family.
Table 4.1: Summary of the 22 experimentally tested subclass B1 genes.
Source data set Gene ID Predicted family
Proposed gene 
name
Assembled 
sequence length 
(aa)
Positive 
Carba NP test
RefSeq Plasmid G04 4 MYO-1 266 Yes
RefSeq Bacteria G06 6 SHD-1 265 Yes
RefSeq Bacteria G09 9 SPS-1 263 Yes
RefSeq Bacteria G12 11 MYX-1 262 Yes
RefSeq Bacteria G13 12 STA-1 262 Yes
RefSeq Bacteria G24 17 259 No
RefSeq Bacteria G27 20 ANA-1 258 Yes
RefSeq Bacteria G28 21 ECV-1 258 Yes
RefSeq Bacteria G29 22 ORR-1 256 Yes
RefSeq Bacteria G31 24 FIA-1 254 Yes
WWTP G33 25 252 Yes
WWTP G37 29 251 Yes
RefSeq Bacteria G52 36 ZOG-1 247 Yes
Patancheru-well G58 41 245 Yes
RefSeq Bacteria G63 46 TTU-1 244 Yes
Pune-river G65 48 242 No
RefSeq Bacteria G67 50 PST-1 243 Yes1
RefSeq Bacteria G69 52 242 No
Patancheru-well G70 53 242 Yes
Oil spill G71 54 240 Yes
RefSeq Bacteria G74 57 SHN-1 238 Yes
RefSeq Bacteria G77 ALI ALI-2 246 Yes
1Strain tested
In Paper III, Sewage eﬄuent from an Indian hospital harbors novel carbapen-
emases and integron-borne antibiotic resistance genes, we searched for novel
metallo-β-lactamases in metagenomic data from sewage eﬄuent from an Indian
hospital. The hospital wastewater was assumed to contain fecal material from
many individuals being treated with antibiotics. Therefore, we hypothesized
that the likelihood of finding ARGs, including novel metallo-β-lactamases, was
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Table 4.2: A list of the predicted metallo-β-lactamases and their closest BLAST hit
against NCBI nr.
Genename MBL subclass Length aa Closest homolog in NCBIprotein database %identityaa Accession number
DIM B1 202 SubclassB1metallo-beta-lactamaseDIM-1[Pseudomonasstutzeri] 100.0 WP_063860203.1
NDM B1 248 MetallobetalactamaseNDM-1[Klebsiella pneumoniae] 100.0 AGC54622.1
IMP B1 240 Beta-lactamase IMP-1precursor [Pseudomonasaeruginosa] 100.0 CRX26419.1
VIM B1 248 SubclassB1metallo-beta-lactamaseVIM-2[Pseudomonadales] 100.0 WP_003108247.1
IMP B1 240 SubclassB1metallo-beta-lactamase IMP-15[Pseudomonasaeruginosa] 100.0 WP_063860575.1
1N26 B1 241 Beta-lactamase [uncultured bacterium] 74.79 ALG03680.1
1N27 B1 242 SubclassB1metallo-beta-lactamase [bacterium336/3] 71.97 WP_054042800.1
2N30* B2 252 ChpA familysubclassB2metallo-beta-lactamase [Aeromonaslacus] 51.48 WP_033113784.1
1N32 B1 241 Hypothetical protein A3D31_07435[Fluviicola sp.
RIFCSPHIGHO2_02_FULL_43_260]
55.04 OGS79779.1
1N4 B1 247 SubclassB1metallo-beta-lactamase [bacterium336/3] 73.55 WP_054042800.1
1N59 B1 244 Hypothetical protein A2041_05420[BacteroidetesbacteriumGWA2_31_9b] 52.7 OFX20903.1
1N6 B1 246 SubclassB1metallo-beta-lactamase [bacterium336/3] 59.5 WP_054042800.1
1N8 B1 234 SubclassB1metallo-beta-lactamase [Flectobacillusmajor] 70.67 WP_044171073.1
1N9 B1 240 Beta-lactamase [uncultured bacterium] 66.53 ALG03680.1
1N7 B1 273 Hypothetical proteinGferi_08260[Geosporobacter ferrireducens] 48.0 AOT69571.1
POM-1 B3 223 B3beta-lactamase [Pseudomonasotitidis] 100.0 ADC79563.1
L-1 B3 210 LW82289.1metallo-beta-lactamase L1familyprotein
[Acinetobacter sp.WC-743]
99.52 WP_009585815.1
3N14 B3 283 SubclassB3metallo-beta-lactamase [Phenylobacteriumsp.Root700] 69.58 WP_056733210.1
3N32* B3 281 BJP_beta_lactamase [uncultured bacterium] 61.59 AIA10847.1
3N33 B3 289 BJP_beta_lactamase [uncultured bacterium] 61.4 AIA10847.1
3N40* B3 290 SubclassB3metallo-beta-lactamase [Phenylobacteriumsp.Root700] 69.96 WP_056733210.1
3N51* B3 299 SubclassB3metallo-beta-lactamase [Novosphingobiumsp.PP1Y]C 70.57 WP_013834039.1
3N55* B3 284 SubclassB3metallo-beta-lactamase [Phenylobacteriumsp.Root700]K 70.82 WP_056733210.1
3N61* B3 297 SubclassB3metallo-beta-lactamase [Croceicoccusmarinus] 57.65 WP_066847047.1
3N73# B3 295 BJP_beta_lactamase [uncultured bacterium] 62.98 AIA10847.1
3N8 B3 297 SubclassB3metallo-beta-lactamase [Sphingomonadaceae]E 55.85 WP_008831296.1
3N1* B3 300 SubclassB3metallo-beta-lactamase [Novosphingobiumsp.Leaf2] 53.0 WP_056771586.1
*These geneswere positive in the CarbaNP test
#This gene wasnegative in the CarbaNP test
increased.
The two probabilistic models used to search for the metallo-β-lactamases were
optimized for subclass B3 and subclass B1/B2, respectively. In addition to
the 20 genes included to construct the B1 model used in Paper II, the 18
experimentally validated genes reported in the paper were included, which
significantly improved the ability to detect new subclass B1 genes. In total,
14 unique full-length genes representing subclass B1, one unique full-length
gene representing subclass B2 and 12 unique full-length genes representing
subclass B3 were predicted. Of the 27 unique full-length predicted genes, seven
were previously characterized: NDM-1, IMP-1, IMP-15, VIM-2, DIM-1, POM-1
and L1. A list of the predicted genes and their closest BLAST hits against
NCBI nr is shown in Table 4.2. The gene predicted as subclass B2, together
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with seven of the predicted subclass B3 genes, was selected for functional
verification. The genes were synthesized and transformed into an E. coli host,
where their ability to hydrolyze carbapenems was assessed using the CarbaNP
test. Six of the seven tested subclass B3 genes and the tested subclass B2 were
positive for the test (Table 4.2). In addition, one of the predicted genes had
the same atypical zinc-binding site as the subclass B1 gene SPS-1 predicted
and validated in Paper II. The results of this paper showed that the diversity
of metallo-β-lactamases in the sewage eﬄuent from the Indian hospital is vast,
with many of the clinically relevant mobile metallo-β-lactamases coexisting
with several previously unknown ones. Because the eﬄuent was expected to
contain pathogens, the results show that this is an environment in which the
recruitment of novel ARGs by pathogens may occur.
4.3 Paper IV
The number of identified metallo-β-lactamases increases every year, and today,
there are more than twice as many characterized genes compared to that only a
decade ago (Widmann et al., 2012; Somboro et al., 2018). Furthermore, this class
of ARGs includes many mobile clinically relevant genes whose evolutionary origin
and mobilization history are largely unknown. Previous studies, including the
ones presented in Papers I-III, have indicated that the number of characterized
metallo-β-lactamases only represents a fraction of the total diversity. Thus, as
the amount of sequence data increases, the number of identified genes will most
likely continue to increase, which calls for a more fine-tuned phylogeny such
that the new genes can be directly placed into an evolutionary context.
In Paper IV, An updated phylogeny of the metallo-β-lactamases, we aimed to
expand the phylogeny of the metallo-β-lactamases to provide a more detailed
picture of their evolutionary history. Using the fARGene method described
in Paper I, we analyzed more than 16 terabases of genomic and metagenomic
data. The microbiomes analyzed were from pristine and polluted environments;
from pig, poultry, and fish farms; and from the human microbiome. A total of
2290 unique metallo-β-lactamases were predicted, and when clustered using a
70% amino acid sequence similarity, these formed 817 gene families, of which
744 did not contain any previously known gene. Representative sequences for
each cluster were used to create phylogenetic trees using an approximative
maximum likelihood approach (Price et al., 2010), one each for subclass B1/B2
and subclass B3. Because of the problems related to inferring phylogenies
from a large number of sequences, all previously known genes within each
subclass together with a smaller set of chosen predicted sequences were used to
create another set of phylogenetic trees using maximum likelihood (Stamatakis,
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Figure 4.6: A phylogenetic tree describing all previously known subclass B1/B2
genes together with selected predicted gene families, with a member of the metallo-β-
lactamase superfamily, glyoxalase II, as an outgroup. The phylum of the host species
is represented by the colored bars on the far right. Gene families that contain genes
predicted in previous studies, but have not yet been functionally validated, are marked
with an asterisk.
2014). For subclass B1/B2, 318 gene families were predicted. Among these, 276
did not contain any previously known subclass B1/B2 gene. The phylogenetic
analysis revealed that subclass B1 could be further divided into five phylogenetic
groups, named B1.1-B1.5 here (Figure 4.6), as previously suggested in Paper
II. The phylogenetic groups primarily correlated to the taxonomy of the host
species, where groups B1.1-B1.2 almost exclusively consisted of genes located
in Proteobacteria, group B1.3 was dominated by Bacteroidetes, and group B1.4
was a mix of Bacteroidetes and Firmicutes. Group B1.5 consisted of genes with
the subclass B1 atypical binding site discovered in Paper II, together with the
structural B1/B2 hybrid SPM-1 and its predicted homologs.
For subclass B3, 499 gene families were predicted, of which 468 were novel. The
phylogenetic analysis showed that subclass B3 could be further divided into four
phylogenetic groups, named B3.1-B3.4 here (Figure 4.7). Similar to subclass B1,
the phylogenetic groups could to a large extent be explained by the phylum of the
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Figure 4.7: A phylogenetic tree describing all previously known subclass B3 genes
together with selected predicted gene families, with a member of the metallo-β-
lactamase superfamily, glyoxalase II, as an outgroup. The phylum of the host species
is represented by the colored bars on the far right. Gene families that contain genes
predicted in previous studies, but have not yet been functionally validated, are marked
with an asterisk.
host species, where group B3.1 consisted of species of the phylum Proteobacteria
(55%) and Firmicutes (26%), group B3.2 was dominated by Bacteroidetes (78%)
but also contained Proteobacteria and Acidobacteria (11% each), and group
B3.3 consisted mainly of Acidobacteria (55%) but also contained genes in
Proteobacteria and Verrucomicrobia (33% and 8%, respectively). Group B3.4
almost exclusively contained genes in Proteobacteria species (96%).
All but two previously characterized acquired subclass B1 genes were located
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in groups B1.1 and B1.2 (Figure 4.6), while the two previously known mobile
subclass B3 genes, together with the three predicted genes located on plasmids
all were located in group B3.4 (Figure 4.7). These groups all have in common
that they almost exclusively consist of genes located in Proteobacterial species.
Thus, it is plausible that today’s clinically relevant metallo-β-lactamases have
mobilized from a species within this phylum. When analyzing the zinc-binding
sites of all previously known genes together with the predicted genes, a total
of eight variants were discovered. Among these, one variant in subclass B1
(present in three gene families) and two in subclass B3 (present in eight and 17
gene families, respectively) were novel.
In conclusion, the results in Paper IV offer a more detailed view of the evolu-
tionary history of the metallo-β-lactamases and show that the diversity of these
genes is larger than what was previously known. The expanded nomenclature
includes information about the phylogenetic groups, providing information
about the taxonomy, possible origin and potential for mobilization.
4.4 Paper V
Tetracyclines are broad-spectrum antibiotics that are used to treat a wide range
of bacterial infections. The efficiency together with the relatively few side effects
has made tetracyclines one of the most used classes of antibiotics (Thaker et al.,
2010). Tetracyclines are also used in subtherapeutic doses to promote growth of
animals such as swine and poultry (Hao et al., 2014). The large consumption
of these antibiotics has resulted in increases in a large variety of resistant
bacteria, with new forms continuously emerging. Tetracycline resistance is
based on three main mechanisms: active export of tetracycline via eﬄux pumps,
ribosomal protection and enzymatic degradation. Over the past few decades, the
number of confirmed tetracycline resistance genes has dramatically increased,
mainly because of horizontal gene transfer between bacteria (Thaker et al.,
2010). Although many of today’s characterized tetracycline resistance genes are
hypothesized to have originated from the environment, their exact evolutionary
origin remains unclear (Chopra and Roberts, 2001; Forsberg et al., 2012).
In Paper V, Comprehensive screening of genomic and metagenomic data reveals
a large diversity of tetracycline resistance genes, the aim was to expand the
number of characterized tetracycline resistance genes to provide a more clear pic-
ture of their diversity, evolutionary history and origin. More than 12 terabases
of genomic and metagenomic data were analyzed using the fARGene method
(Paper I), with three models optimized to identify tetracycline resistance genes
of the three mechanisms: eﬄux pumps, ribosomal protection and enzymatic
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Figure 4.8: Phylogenetic tree of the predicted and previously known enzymatic
tetracycline resistance genes. The number of unique genes in each group is presented
within square brackets. The gene shown to be functional in E. coli is represented with
an asterisk and the gene families that did not function in E. coli are represented with
a hash sign.
degradation. A total of 1354 tetracycline resistance genes were predicted that
were clustered into 195 gene families using a 70% sequence similarity, of which
164 did not contain any previously known gene. The ribosomal protection
genes were the most diverse, followed by eﬄux genes and enzymatic degradation
genes, with 116, 53 and 26 predicted gene families, respectively. Furthermore,
phylum analysis of the identified species carrying tetracycline resistance genes
showed that ribosomal protection genes were overrepresented in Firmicutes,
Bacteroidetes and Actinobacteria while underrepresented in Proteobacteria;
eﬄux pump genes were overrepresented in Proteobacteria while underrepre-
sented in Firmicutes and Actinobacteria; and enzymatic degradation genes were
overrepresented in Bacteroidetes while underrepresented in Proteobacteria.
Seventeen of the predicted novel genes were selected for functional verification
in E. coli, of which five, six and six were enzymatic degradation, ribosomal
protection and eﬄux pump genes, respectively. Of the tested genes, seven
induced a resistance phenotype when expressed in E. coli, of which one was
an enzymatic degradation gene and three were ribosomal protection and eﬄux
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pump genes, respectively.
Phylogenetic trees were created for the three main mechanisms of tetracycline
resistance using representative sequences from each gene family. The enzymatic
degradation genes, which were rare, were divided into two groups, where the
previously known mobile gene tet(X) (Whittle et al., 2001) was located in
one group together with two homologs, while the remaining previously known
enzymatic degradation genes were located in a separate group (Figure 4.8). The
tree describing the predicted ribosomal protection genes was divided into two
groups (Figure 4.9). The majority of the previously known mobile ribosomal
protection genes were closest related to genes located in the phylum Firmicutes,
except for the gene otr(A), which was surrounded by genes located in species
of the phylum Actinobacteria. In the Actinobacteria group, there was a clade
with genes located in Proteobacterial species, among which some were located
on plasmids, indicating mobilization events from Actinobacterial species to
Proteobacterial species. The phylogenetic tree describing the eﬄux pump genes
is shown in Figure 4.10, and here, the previously known genes were distributed
over the entire tree. However, the previously known eﬄux pump genes located
on plasmids clustered together and were mainly surrounded by genes located in
Proteobacterial species.
The results from this paper increase the knowledge of the potential tetracycline
resistome and further describe the reservoir of resistance genes harbored by
environmental and commensal bacteria. The phylogenetic analysis indicated
that the mobile tetracycline resistance genes were mobilized from different phyla,
where ribosomal protection genes originate from Firmicutes and Actinobacteria,
while eﬄux pump genes originate from Proteobacteria. We further conclude
that enzymatic degradation genes are scarce and that their evolutionary origin
remains unknown.
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Figure 4.9: Phylogenetic tree of the predicted and previously known ribosomal
protection genes. The number of unique genes in each family is presented within
square brackets. The gene families functional in E. coli are represented with an
asterisk and the gene families that did not function in E. coli are represented with a
hash sign.
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Figure 4.10: A phylogenetic tree describing the previously known eﬄux genes of
MFS group 1 together with the predicted genes. The number of unique genes in each
group is presented within square brackets. The gene families functional in E. coli are
represented with an asterisk and the gene families that did not function in E. coli are
represented with a hash sign.
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4.5 Paper VI
The fully synthetic antibiotic class quinolones began clinical use in 1962, and
later in the 1980s, the addition of fluorine to the quinolone yielded the fluoro-
quinolones. Because the antibiotic was not derived from natural components,
it was considered unlikely that fluoroquinolone resistance would emerge. Nev-
ertheless, in 1998, the first plasmid-mediated quinolone resistance (qnr) gene
was discovered. Since then, the qnr genes have rapidly spread and are now
distributed globally and are present in many bacterial genera. As with most
other ARGs, the qnr genes are assumed to have originated from the environ-
ment (Sánchez et al., 2008). Although several families of qnr genes have been
discovered over the past decade, their true abundance and diversity are still
unknown.
The aim of paper VI, Computational discovery and functional validation of novel
fluoroquinolone resistance genes in public metagenomic data sets, was to screen
a high number of genomic and metagenomic datasets to discover previously
unknown qnr genes and to estimate their abundances in environmental and
commensal bacterial communities. A total of almost 13 terabases of genomic
and metagenomic data were analyzed using a computational pipeline based
on an HMM. A total of 362 843 qnr gene fragments were identified, and 611
Figure 4.11: A phylogenetic tree describing the relationships between the previously
known plasmid-mediated qnr genes and the predicted genes validated in Paper VI.
The bar plot shows the fold change of ciprofloxacin minimum inhibitory concentration
for all tested genes with three separate measurements each.
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qnr genes were predicted. Among the 611 predicted qnr genes, all previously
described plasmid-mediated qnr gene families were identified. Fifty-two of the
predicted genes were reconstructed from the metagenomic data, of which 20 were
not present or annotated as fluoroquinolone resistance genes in GenBank and
therefore considered putatively novel qnr genes. Nine of these were selected for
experimental verification, of which six showed an increased MIC to ciprofloxacin
when expressed in E. coli (Figure 4.11). This paper provided the most exhaustive
search for qnr genes in both genomic and metagenomic data ever conducted
and contributed to the extended knowledge about their relative abundance in
various bacterial communities.
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5 Conclusions and discussion
In this thesis, bioinformatical methods and probabilistic models have been
developed and used to investigate the unknown resistome of, in particular, genes
providing resistance towards β-lactams, tetracyclines and fluoroquinolones. The
methods have mainly been applied to fragmented metagenomic data from
a diverse set of microbial communities, such as human- and animal-related
microbiomes, as well as pristine and polluted environments. In addition, NCBI
GenBank’s repository of genomes, plasmids and nonredundant sequences has
continually been explored. In total, more than 50 terabases of sequence data
have been analyzed, resulting in the prediction of 4484 unique putative ARGs.
The predicted genes were organized into approximately 1400 gene families, and
among these, there were approximately 1000 gene families that did not contain
any previously known ARG. In other words, approximately 2/3 of all predicted
gene families in this thesis were novel, indicating that the current knowledge of
ARGs only reflects the tip of the iceberg of the total resistome. Of the novel
predicted genes, 54 have been functionally validated, and among these, 37 were
shown to be functional when expressed in an Escherichia coli host.
We identified ARGs in almost every studied environment, supporting the hy-
pothesis that antibiotic resistance determinants are present everywhere (Allen
et al., 2010; D’Costa et al., 2011). In addition, the diversity of ARGs was
shown to be vast, particularly in the environmental microbiomes, in which
many new ARGs were predicted. However, the relative abundance of ARGs
was generally higher in environments with different types of pollution, such
as two rivers in India (Papers II, IV-VI), sewage eﬄuent from a hospital in
India (Paper III), aquaculture systems and fecal samples from poultry and
pigs, where antibiotics are expected to have been extensively used (Paper IV).
Nevertheless, the number of predicted new ARGs in these environments still, in
many cases, greatly exceeded the number of identified previously known ARGs.
In addition, many of the studied environments contained a large number of clin-
ically relevant previously known ARGs; in particular, the sewage eﬄuent from
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an Indian hospital contained the majority of the currently clinically relevant
carbapenemases NDM, VIM, IMP, KPC and OXA-48. Several new resistance
genes coding for carbapenem resistance coexisted with these genes, suggesting
that even if mobile ARGs are widely distributed within a microbial community,
there still appears to be room for other ARGs with similar resistance profiles.
However, the genes identified in Paper III were reconstructed from metagenomes;
thus, an analysis of the genetic context and potential mobility was not possible.
Nevertheless, even though they may be intrinsic, there is still a risk that they
can be mobilized and transferred into pathogens (Stokes and Gillings, 2011;
Ebmeyer et al., 2019a,b).
Phylum analysis of the predicted ARGs together with the previously known
revealed that some phyla were overrepresented carriers of certain types of ARGs.
Of the metallo-β-lactamases, subclass B1 genes were overrepresented in species
of the phylum Bacteroidetes, while subclass B3 genes were overrepresented in
species of the phylum Proteobacteria and underrepresented in Bacteroidetes
species (Papers II and IV). For the tetracycline resistance genes, the riboso-
mal protection genes were overrepresented among Firmicutes, Bacteroidetes
and Actinobacteria while underrepresented among Proteobacteria. The eﬄux
pumps were overrepresented among Proteobacteria while underrepresented in
Firmicutes and Actinobacteria (Paper V). The predicted enzymatic tetracycline
resistance genes were overrepresented among Bacteroidetes; however, all but one
of the identified Bacteroidetes species carrying enzymatic genes were homologs
to the mobile tet(X) (Whittle et al., 2001). It therefore appears that some types
of ARGs are more widely distributed among certain phyla compared to others.
Although it is difficult to know for certain what causes this discrepancy, it could
be a consequence of that some types of ARGs might be less compatible with
bacteria from specific phyla, or that the barriers for horizontal gene transfer have
hindered the genes from traveling vast taxonomical distances, or a combination
thereof.
Phylogenetic analysis of the predicted and previously known genes further
showed that many ARGs clustered based on the phylum of the host species.
Interestingly, almost all of the previously known mobile subclass B1 genes,
including the clinically relevant NDM, VIM and IMP, were located in parts
of the phylogenetic tree that were dominated by predicted ARGs located in
Proteobacterial species. The same pattern could be observed for subclass B3,
where the two previously known mobile genes together with the predicted
genes in Paper IV located on plasmids were most closely related to predicted
ARGs located in Proteobacterial species. This result suggests that the acquired
metallo-β-lactamases that we see today in clinical settings have mobilized from a
Proteobacterial species. Furthermore, note that among subclass B1, there are 13
confirmed acquired genes to date, many being widespread and clinically relevant,
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while among subclass B3, there are only two mobile genes (Somboro et al., 2018;
Boyd et al., 2019; Wachino et al., 2011), not counting the three genes located
on plasmids predicted in Paper IV. However, their resistance spectra are very
similar (Bebrone, 2007) and, based on the number and in which environments
they are predicted, they appear to be approximately equally diverse.
For the tetracycline resistance, the phylogenetic analysis in Paper V revealed
that the ribosomal protection genes could be divided into two groups. The first
group contained all previously known ribosomal protection genes except for the
otr(A) gene. In this group, the predicted ARGs located in genomes were for
all but one located in species of the phylum Firmicutes. Thus, it is plausible
that these genes have mobilized from a species from the Firmicutes phylum.
However, the second group containing otr(A) consisted almost exclusively of
species within the phylum Actinobacteria. Within this group, there was a small
clade of genes located in Proteobacterial species, some of which were located on
plasmids. Hence, it appears that these genes have mobilized from Actinobacteria.
Furthermore, the previously known mobile eﬄux genes, which are most often
found in Proteobacterial species, were also surrounded by predicted genes mainly
located in Proteobacterial species, indicating that this is also the phylum from
which they have mobilized. Taken together, phylogenetic analysis can provide
clues about the mobilization process and evolutionary origin of clinically relevant
ARGs. However, we did not find any chromosomally located ARGs that were
closely related to the previously known mobile genes. This result suggests that
their origin might be from species that have not yet been sequenced or that the
mobilization events occurred so far back in time that the original gene sequences
are not conserved. Although there is evidence of relatively recent mobilization
events (Ebmeyer et al., 2019a,b), the identified cases are few, and it is far from
evident that this would be the case for all ARGs. Thus, knowledge about this
process is rather scarce, and we do not fully understand the mobilization process,
nor do we know the evolutionary origin of the majority of today’s clinically
relevant ARGs (Forsberg et al., 2012). More identified ARGs are therefore
required to infer better phylogenies to increase the knowledge of this process
and to better the evolutionary history at a higher detail.
In Papers II and IV, we also analyzed the variations of zinc-binding sites of the
metallo-β-lactamases. In Paper II, we identified a new gene, SPS-1, that had an
atypical and previously unseen variant of the zinc-binding sites for the subclass
B1 genes. The gene was confirmed to hydrolyze carbapenems, and further
studies from another research group showed that SPS-1 had a more narrow
resistance spectrum compared to the previously known subclass B1 (Cheng
et al., 2018). In Paper IV, we identified additional subclass B1 genes that had
the same atypical binding site as SPS-1 but also predicted three genes with a
third variant of the subclass B1 zinc-binding site. For the subclass B3 genes,
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we predicted two previously unseen variants of zinc-binding sites present in a
total of 35 genes, in addition to the two previously known variants. However,
the structure of the predicted genes needs to be resolved, and they have to be
functionally verified to be able to draw any conclusions on how these changes
in zinc-binding sites affect the biochemical properties. Nevertheless, the results
show that the variation among the metallo-β-lactamase binding sites is far
more diverse than what was previously known, and further research about their
functional diversity is therefore needed.
Although the results presented in this thesis have shown that the resistome is
much larger and more diverse than what has been observed in the clinical setting,
it is important to note that most of these genes do not pose an immediate threat
to public health (Martínez et al., 2015). For an ARG to become relevant in the
clinical setting, it needs to be located in a pathogenic or at least an opportunistic
bacterium. Furthermore, the ARG needs to be functionally compatible with the
host and properly expressed to be efficient. However, if the ARG is located on a
mobile genetic element, it has the potential to become, if not already, problematic
because it has a higher potential to spread between strains and species. An ARG
located on a mobile genetic element in a pathogenic bacteria where it is also
efficient would therefore constitute a much larger risk to public health. Several
of the ARGs predicted in this thesis that were functional in E. coli were already
located in opportunistic bacteria. This included, for example, the tetracycline
eﬄux pump gene located on Ochrobactrum anthropi (Aguilera-Arreola et al.,
2018) (Paper V) and the subclass B1 metallo-β-lactamase (named MYO-1)
located in Myroides odoratimimus (Hu et al., 2016) (Paper II). The latter was
furthermore located on a plasmid and thus already has a theoretical possibility
to transfer to other species. Moreover, three ribosomal protection genes and
two eﬄux pumps predicted to provide tetracycline resistance, identified in
Paper V, were located on plasmids in soil-related bacteria. Here, one of the
plasmid-located ribosomal protection genes was shown to be functional in E.
coli. Additionally, three plasmid-located genes encoding subclass B3 metallo-β-
lactamases were predicted in Paper IV. However, an ARG located on a plasmid
does not necessarily imply that the ARG can be horizontally transferred between
bacteria because there are many barriers reducing the possibility of genes moving
between distantly related species. However, an ARG located on a broad-range
plasmid makes it more likely to occur (Thomas and Nielsen, 2005). In addition,
the acquisition of an ARG is often associated with a fitness cost, often leading
to a reduction in the growth rate for the bacteria (Andersson and Levin, 1999).
Therefore, if the ARG does not have any other beneficial function, the bacteria
will not benefit from carrying the gene in the absence of antibiotics (Andersson
and Hughes, 2010). Furthermore, an ARG can only be transferred horizontally
if the carrier and the donor are in contact; hence, an ARG discovered in bacteria
living in an environment far from any human-linked environment will be less
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likely to find its way to a human pathogen (Baquero et al., 2009; Martínez, 2012).
However, with the increase in human population and inefficient wastewater
treatment plants, more human and commensal bacteria are disseminated in the
environment, and the risk of such a transfer event thus increases (Martínez,
2008).
In environments where the abundance and diversity of ARGs are large, the
probability of an ARG being mobilized will be higher. If the environment is
also subjected to selection pressure, such as antibiotic pollution, and the fitness
cost is not too high or negligible due to selection pressure, then the likelihood
for the recipient bacteria to maintain the ARGs is further increased (Andersson
and Hughes, 2010; Gullberg et al., 2014; Bengtsson-Palme and Larsson, 2015;
Bengtsson-Palme et al., 2017a). Consequently, there will be environments in
which the circumstances are beneficial for recruiting novel ARGs. Many of the
metagenomes in which we find new ARGs comes from such environments, for
instance, sewage eﬄuent from an Indian hospital (Paper III), a river in India
that flows through the city Pune and is subjected to untreated wastewater
(Marathe et al., 2017) (Papers II, IV, V, VI), antibiotic-polluted lake and river
(Papers I, V), fecal samples from animal farms and water from fish farms (Papers
IV, V). Indeed, many of these environments showed a high diversity and relative
abundance of ARGs. Furthermore, all of these environments are expected to
harbor human- and animal-related bacteria; therefore, potential dissemination
to human pathogens cannot be excluded. However, some of the identified
genes are likely already located in human-related bacteria that stem from, for
instance, fecal contamination (Pune river and hospital eﬄuent). Nevertheless,
since mobilization events probably occur continuously, the high diversity and
abundance of ARGs in these environments increase the risk of an ARG being
mobilized and recruited, and due to the diversity, eventually one that is efficient
enough to be fixated by the bacterial community.
The amount of available sequencing data will undoubtedly continue to increase.
With this comes the requirement for efficient and reliable methods to analyze
the massive amounts of information. The method presented in Paper I was
explicitly developed to predict new ARGs from large amounts of fragmented
metagenomic data and provides an efficient way to identify resistance genes
without the problematic de novo assembly. The method was able to identify all
previously known ARGs included in the study and outperformed the compared
competing methods in the identification of short-read sequences from new ARGs
with a known resistance phenotype. The method was developed such that it
could be applied to any class of ARGs and can therefore be used to, in theory,
characterize the remaining unknown resistome of today’s known resistance
classes. However, the method based on probabilistic gene models in the form of
profile HMMs requires prior knowledge of the gene class of interest. Therefore,
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in contrast to functional metagenomics, it is not capable of detecting new forms
of resistance but rather only homologs to the previously characterized. It is
therefore essential to continue the search for new ARGs; as more genes are being
characterized and added to databases, the search area will expand. Furthermore,
it is crucial that the genes reported as ARGs to the databases are phenotypically
tested; otherwise, there will be a downward spiral where false positives might be
included in model creations, enabling even more false positives to be reported.
Throughout this thesis we have therefore given formal names only to the ARGs
that have been phenotypically confirmed. With well-curated and comprehensive
databases, the future for the identification of ARGs using methods such as the
one presented in this thesis looks bright, and we will most likely have a much
more comprehensive picture of the available resistome in the coming years.
In conclusion, this thesis has contributed to the delineation of the present
resistome and has significantly increased the number of characterized resistance
genes. Analysis of the predicted and characterized genes has provided insights
about the diversity, their evolutionary history and potential origin. Better
knowledge of these genes is crucial to hinder the ongoing flow of genes provid-
ing resistance to both new and currently available antibiotics, from harmless
bacteria to human pathogens. Increased knowledge about the resistome and
the dispersion routes can enable management strategies to be implemented
to limit the presence of and spread from environments where the potential
for mobilization and selection of ARGs are elevated. Moreover, information
about the structural and functional diversity of the resistome can be taken into
account when developing new antibiotics. Furthermore, whole-genome sequenc-
ing is being progressively implemented as a diagnostic tool; therefore, with
more comprehensive knowledge about the resistome and reliable and efficient
bioinformatical methods, novel ARGs can be detected at an early stage, and
actions can be taken before they become a serious issue for human health.
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